Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 9Rectal Neoplasms 5Colorectal Neoplasms 5Colonic Neoplasms 4Neoplasm Metastasis 1Gastric Cancer Stage 1Colorectal Cancer Metastatic 1Adenocarcinoma 1

Interventions

aflibercept 3Irinotecan 2Bevacizumab 2XELOX 1Vemurafenib 1Panitumumab 1Leucovorin 1IFL protocol 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Cancer Metastatic × XELOX × Clear all
NCT01910610 2024-03-12

STRATEGIC-1

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Unknown
464 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡